Back to board

Global Medical Affairs Strategy Asset Lead

Bristol Myers Squibb · United States · US

Medical Affairs
Remote
physician
Pharmacist
Dentist
Demand80
Career growth78
Healthcare fit72
Remote potential80
Salary band
USD 173k – 210k
5-year outlook
Senior oncology medical affairs compensation is generally strong, and the posted US range ($173k–$210k) signals a leadership-track band. Five-year growth will depend on oncology/radiopharma experience and progression into broader medical affairs leadership.
Clinical license
Not required
Applicant reach
narrow
Seniority
lead
Employment type
full-time
Date found
2026-11-20

Intelligence details

Flexible work details

Engagement type
Permanent
Hours
Full-time
Eligible countries
United States
Profession fit
physician, Pharmacist, Dentist
Rate period
Annual

Listing via Himalayas.

Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.

Why this is worth applying to

Clinicians with oncology expertise and prior pharmaceutical/biotech medical affairs experience should consider this, especially if they have radiopharmaceutical or prostate cancer exposure. Clinicians without medical affairs experience are unlikely to be competitive despite the strong clinical relevance.

Who should apply

Oncology-trained physicians, pharmacists, or IMGs with 3–5+ years of medical affairs experience in pharma/biotech; candidates with radiopharmaceutical, prostate cancer, KOL engagement, publications, and cross-functional matrix experience are strongest.

CV angle

Frame real oncology clinical experience as scientific expertise, then emphasize medical affairs accomplishments: medical strategy contributions, evidence planning, publications/congress/advisory board support, KOL engagement, clinical trial design or recruitment support, cross-functional collaboration, and AI-enabled workflow improvements. Do not claim prior medical affairs experience unless genuine.

Skills to highlight

  • Global medical strategy
  • Oncology scientific expertise
  • KOL engagement
  • Scientific communication and publications
  • Clinical trial design and recruitment support
  • Cross-functional matrix leadership
  • Medical evidence planning
  • AI-enabled decision-making

Role summary

Leads global medical affairs strategy for an early oncology pipeline asset, aligning medical evidence, scientific communication, clinical development support, KOL engagement, publications, advisory boards, and cross-functional strategy across R&D, Commercial, Access, and Communications.

We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.